BC-006 (BaseCure Therapeutics)

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameBC-006 (BaseCure Therapeutics)
Drug Alias NameBC-006BC-006 (BaseCure Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInhibin beta E chain inhibitors
TargetsInhibin beta E chain
Therapy Area/IndicationsBody WeightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBaseCure Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeisi Ke (Shanghai) Biotechnology Co LtdBaseCure Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBody WeightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A